Tag: AusBioTech

Tech industry welcomes board, awaits investment mandate

Posted on   |  by Brandon How
Industry bodies have cautiously welcomed Industry and Science minister Ed Husic’s eight appointments to National Reconstruction Fund board, with some reserving judgement until details on the investment mandate are...

Industry-first ESG guide for small biotechs

Posted on   |  by Nicole Bittar
Helping companies see the benefit of being commonly understood is the essence of ensuring a comparable environmental, social and governance (ESG) practice for biotechs and medtechs.  This provided the...

AusBiotech unveils 10-year blueprint for the biotech sector

Posted on   |  by Brandon How
Life sciences industry representative body AusBiotech has launched a 10-year strategy for the biotechnology sector in an effort to “herald an era of Australian discovery, translationa and innovation”. The...

End of uncertainty as RDTI reforms finally pass

Posted on   |  by Denham Sadler
The federal government’s “enhanced” reforms to the research and development tax incentive passed Parliament just days after being announced, ending two and a half years of uncertainty for those...

AusBiotech sector locked out of COVID response

Posted on   |  by Denham Sadler
Crucial research and thousands of jobs are at risk because the Australian biotech industry has been largely locked out of the federal government’s COVID-19 support efforts, according to AusBiotech....

‘Ill-informed’ R&D tax changes hit biotech

Posted on   |  by Denham Sadler
The federal government’s “ill-informed” reforms to the research and development tax incentive will damage Australia’s burgeoning life sciences sector at a time when it is at the forefront of...

BioTech is hardest hit by R&D changes

Posted on   |  by James Riley
The Life Sciences industry in Australia will be hit disproportionately hard by proposed changes to the R&D Tax Incentive, putting smaller companies at risk and threatening the sector’s ability...

R&D changes to ‘devastate’ biotech

Posted on   |  by James Riley
Potential changes to the R&D tax incentive would “devastate” the booming biotechnology industry in Australia, a new report has found. The Biotechnology Industry Position Survey 2017 found that the...